Insights from 2023 WCLC


 

WCLC 2023 Insights: "ILLUMINATE - Efficacy & Safety of Durvalumab-Tremelimumab & Chemotherapy in EGFRm NSCLC Following Progression on EGFR Inhibitors"

89 views
September 22, 2023
Comments 0
Login to view comments. Click here to Login